These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8956350)

  • 1. The efficacy of L-methadone and racemic methadone in substitution treatment for opiate addicts--a double-blind comparison.
    Scherbaum N; Finkbeiner T; Leifert K; Gastpar M
    Pharmacopsychiatry; 1996 Nov; 29(6):212-5. PubMed ID: 8956350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs. methadone.
    Seifert J; Metzner C; Paetzold W; Borsutzky M; Passie T; Rollnik J; Wiese B; Emrich HM; Schneider U
    Pharmacopsychiatry; 2002 Sep; 35(5):159-64. PubMed ID: 12237786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of racemic D,L-methadone and L-methadone in substituted patients--a randomized controlled study.
    Verthein U; Ullmann R; Lachmann A; Düring A; Koch B; Meyer-Thompson HG; Schmidt R; Reimer J; Haasen C
    Drug Alcohol Depend; 2005 Nov; 80(2):267-71. PubMed ID: 15916866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasability and safety of transfer from racemic methadone to (R)-methadone in primary care: clinical results from an open study.
    Soyka M; Zingg C
    World J Biol Psychiatry; 2009; 10(3):217-24. PubMed ID: 19629858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescribing methadone for the opiate addict: a problem of dosage conversion.
    Johns AR; Gossop M
    Drug Alcohol Depend; 1985 Sep; 16(1):61-6. PubMed ID: 4064909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid detoxification with buprenorphine, clonidine, or methadone in hospitalized heroin-dependent patients with HIV infection.
    Umbricht A; Hoover DR; Tucker MJ; Leslie JM; Chaisson RE; Preston KL
    Drug Alcohol Depend; 2003 Apr; 69(3):263-72. PubMed ID: 12633912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of buspirone in the treatment of opioid withdrawal.
    Buydens-Branchey L; Branchey M; Reel-Brander C
    J Clin Psychopharmacol; 2005 Jun; 25(3):230-6. PubMed ID: 15876901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Craving and drug reward: a comparison of methadone and clonidine in detoxifying opiate addicts.
    Dawe S; Gray JA
    Drug Alcohol Depend; 1995 Oct; 39(3):207-12. PubMed ID: 8556969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised double-blind comparison of lofexidine and clonidine in the out-patient treatment of opiate withdrawal.
    Carnwath T; Hardman J
    Drug Alcohol Depend; 1998 May; 50(3):251-4. PubMed ID: 9649979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety, efficacy, and long-term results of a modified version of rapid opiate detoxification under general anaesthesia: a prospective study in methadone, heroin, codeine and morphine addicts.
    Hensel M; Kox WJ
    Acta Anaesthesiol Scand; 2000 Mar; 44(3):326-33. PubMed ID: 10714849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of buprenorphine and methadone maintenance in opiate addicts.
    Eder H; Fischer G; Gombas W; Jagsch R; Stühlinger G; Kasper S
    Eur Addict Res; 1998; 4 Suppl 1():3-7. PubMed ID: 9767199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of buspirone in withdrawal from opiates.
    Rose JS; Branchey M; Wallach L; Buydens-Branchey L
    Am J Addict; 2003; 12(3):253-9. PubMed ID: 12851021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accelerated lofexidine treatment regimen compared with conventional lofexidine and methadone treatment for in-patient opiate detoxification.
    Bearn J; Gossop M; Strang J
    Drug Alcohol Depend; 1998 May; 50(3):227-32. PubMed ID: 9649976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prescribing of methadone and other opioids to addicts: national survey of GPs in England and Wales.
    Strang J; Sheridan J; Hunt C; Kerr B; Gerada C; Pringle M
    Br J Gen Pract; 2005 Jun; 55(515):444-51. PubMed ID: 15970068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Buprenorphine/naloxone versus methadone and lofexidine in community stabilisation and detoxification: A randomised controlled trial of low dose short-term opiate-dependent individuals.
    Law FD; Diaper AM; Melichar JK; Coulton S; Nutt DJ; Myles JS
    J Psychopharmacol; 2017 Aug; 31(8):1046-1055. PubMed ID: 28631527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sublingual buprenorphine and methadone maintenance treatment: a three-year follow-up of quality of life assessment.
    Giacomuzzi SM; Ertl M; Kemmler G; Riemer Y; Vigl A
    ScientificWorldJournal; 2005 May; 5():452-68. PubMed ID: 15925962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: results from a randomized study.
    Soyka M; Zingg C; Koller G; Kuefner H
    Int J Neuropsychopharmacol; 2008 Aug; 11(5):641-53. PubMed ID: 18205978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Buprenorphine versus methadone maintenance for the treatment of opioid dependence.
    Fischer G; Gombas W; Eder H; Jagsch R; Peternell A; Stühlinger G; Pezawas L; Aschauer HN; Kasper S
    Addiction; 1999 Sep; 94(9):1337-47. PubMed ID: 10615719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Appropriateness of methadone maintenance treatment for opiate addiction: evaluation by an expert panel.
    Vader JP; Hämmig R; Besson J; Eastus C; Eggenberger C; Burnand B
    Soz Praventivmed; 2003; 48 Suppl 1():S1-14. PubMed ID: 12891872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Buprenorphine or methadone for detoxification of young opioid addicts?].
    Ebner R; Schreiber W; Zierer C
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S108-10. PubMed ID: 15570521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.